Salvage oesophagectomy after local failure of definitive chemoradiotherapy

被引:77
作者
Gardner-Thorpe, J. [1 ]
Hardwick, R. H. [1 ]
Dwerryhouse, S. J. [1 ]
机构
[1] Addenbrookes Hosp, Oesophagogastr Ctr, Cambridge CB2 2QQ, England
关键词
D O I
10.1002/bjs.5865
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Definitive chemoradiotherapy (CRT) is one treatment option for locally advanced oesophageall carcinoma. CRT typically consists of high-dose (50-66 Gy) external beam radiotherapy concurrent with 5-fluorouracil and cisplatin. When definitive CRT fails to achieve local control, salvage oesophagectomy is frequently the only treatment available that can offer a chance of long-term survival. Methods: Online databases were searched for publications relating to salvage oesophagectomy and definitive CRT. Nine series containing a total of 105 patients were reviewed. Demographics, indications for surgery, type of resection, complications and outcome data were extracted. Results: Each centre performed one to three salvage resections per year comprising 1.7-4.1 per cent of the oesophagectomy workload. The overall anastomotic leak rate was 17.1 per cent. The in-hospital mortality rate was 11.4 per cent. Five-year survival rates of 25-35 per cent were achieved. Prognostic factors for increased survival were R0 resection (P = 0.006) and longer interval between CRT and recurrence (P = 0.002). Conclusion:. Salvage resection after CRT is feasible for selected patients but is a formidable undertaking. Restaging investigations after CRT for potentially resectable tumours in fit candidates should include endoscopy and positron emission tomography-computed tomography. Salvage oesophagectomy is carried out with the goal of cure and it should be attempted only if an RO resection is technically possible.
引用
收藏
页码:1059 / 1066
页数:8
相关论文
共 37 条
  • [1] [Anonymous], 2002, CLASSIFICATION MALIG
  • [2] Bancewicz J, 2002, LANCET, V359, P1727
  • [3] Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma
    Bates, BA
    Detterbeck, FC
    Bernard, SA
    Qaqish, BF
    Tepper, JE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 156 - 163
  • [4] Beseth BD, 2000, AM SURGEON, V66, P827
  • [5] A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102):: chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer
    Bonnetain, F
    Bouché, O
    Michel, P
    Mariette, C
    Conroy, T
    Pezet, D
    Roullet, B
    Seitz, JF
    Paillot, B
    Arveux, P
    Milan, C
    Bedenne, L
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (05) : 827 - 834
  • [6] Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 patterns of care study
    Coia, LR
    Minsky, BD
    Berkey, BA
    John, MJ
    Haller, D
    Landry, J
    Pisansky, TM
    Willett, CG
    Hoffman, JP
    Owen, JB
    Hanks, GE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 455 - 462
  • [7] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [8] Daly JM, 1996, CANCER, V78, P1820, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO
  • [9] 2-Z
  • [10] Factors influencing outcome following radio-chemotherapy for oesophageal cancer
    Denham, JW
    Burmeister, BH
    Lamb, DS
    Spry, NA
    Joseph, DJ
    Hamilton, CS
    Yeoh, E
    OBrien, P
    Walker, QJ
    [J]. RADIOTHERAPY AND ONCOLOGY, 1996, 40 (01) : 31 - 43